University of Utah, John Moran Eye Center
Welcome,         Profile    Billing    Logout  
 7 Trials 
6 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bernstein, Paul S
NCT03316300 / 2017-003234-82: A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

Completed
3
120
Europe, US, RoW
NT-501, Sham Procedure
Neurotech Pharmaceuticals, The Lowy Medical Research Institute Limited
Macular Telangiectasia Type 2 (MacTel)
08/22
09/22
Moshirfar, Majid
Apricity-B, NCT06100952: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Recruiting
3
400
US
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment
Epion Therapeutics
Keratoconus
11/25
11/25
NCT05611294: Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Active, not recruiting
N/A
42
US
Topography Guided LASIK Surgery, Small Incision Lenticule Extraction Surgery
Hoopes Vision, Alcon Research
Myopia, Astigmatism
05/25
06/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Jones, Kaylie
Platypus, NCT05902962: SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects

Recruiting
1
20
US
VP-001
PYC Therapeutics
Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11
05/24
05/24
NCT05573984: Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting
N/A
50
US, RoW
PYC Therapeutics
Retinitis Pigmentosa, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Dystrophy Rod, Retinal Dystrophy Rod Progressive
12/26
04/27

Download Options